Unicycive Therapeutics Inc (UNCY) Financials

$5.30

$0.18 (3.52%)

As on 10-Sep-2026 14:33EDT

Market cap

$141 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	0.68	0.95	--
Cost of Revenue	0.36	0.57	0.43	0.28	0.01	0.00
Gross Profit	-0.36	-0.57	-0.43	0.68	0.95	0.00
Operating Expenses	32.93	28.95	32.12	21.45	19.00	8.98
Operating Profit (EBIT)	-33.14	-29.52	-32.12	-20.77	-18.05	-8.98
Other Income	--	--	--	--	--	--
Profit before Tax	-35.22	-26.56	-36.73	-30.54	-18.06	-10.02
Provision for Tax	--	--	-1.10	0.12	0.01	0.62
Profit after Tax (Net Income)	-35.22	-26.56	-36.73	-30.54	-18.06	-10.63
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-10.02

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	53.27	30.20	7.43	-3.81	-0.47	16.48
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.06	--	0.12	0.47	0.00	0.16
Current Liabilities	18.70	18.94	24.12	17.53	3.28	2.11
Total Liabilities	90.73	49.14	31.67	14.19	2.82	18.74

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.71	0.17	0.72	0.79	0.17	0.33
Current Assets	71.32	48.96	30.95	13.40	2.64	18.41
Total Assets	90.73	49.14	31.67	14.19	2.82	18.74
Total Debt*	0.67	0.20	0.77	0.81	0.20	0.34
Net Current Assets	52.62	30.02	6.83	-4.14	-0.64	16.31

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-31.32	-28.58	-18.28	-15.65	-5.77
Cash Flow from Investing Activities	--	-12.10	-0.07	-0.01	0.00	-0.03
Cash from Financing Activities	--	46.47	45.09	27.54	-0.47	22.38
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.67	-1.33	-4.71	-8.79	-11.86	-7.09
Cash EPS ($)	--	-1.31	-4.66	-8.72	-11.75	-7.08
Adjusted Book Value ($)	--	1.52	0.95	--	--	10.99
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.57	-3.67	-5.26	-10.28	-3.85
Free Cash Flow per Share ($)	--	-1.58	-3.67	-5.26	-10.28	-3.86

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-137.59	-1,411.03	1,872.14	-218.24	-127.62
ROE (%)	-84.40	-141.14	-2,028.11	1,428.96	-225.55	-153.94
ROA (%)	-52.46	-65.73	-160.18	-359.15	-167.55	-112.22
EBIT Margin (%)	--	--	--	-4,512.89	-1,898.21	--
Net Margin (%)	--	--	--	-4,525.04	-1,899.47	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	-0.29	--	--
EBIT Growth (%)	-11.92	27.75	-20.34	-68.75	-101.09	-344.41
Net Profit Growth (%)	-11.83	27.70	-20.25	-69.09	-69.90	-323.92
EPS Growth (%)	54.85	0.72	0.46	0.26	-0.67	-3.31
Book Value Growth (%)	48.19	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.32	-0.17	-0.10	-0.05	-0.29
Price / Book Value	2.64	3.80	0.83	-0.79	-1.77	0.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.03	-2.85	0.53	0.19	-0.03	1.47
Close Price ($)	4.69	5.77	7.94	8.68	5.40	20.60
High Price ($)	8.74	11.00	18.18	28.70	23.50	87.30
Low Price ($)	3.72	3.72	2.02	4.00	4.01	17.50
Market Cap ($ Cr)	141.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.10	-0.21	-0.43	0.02
Short term debt to equity ratio	0.01	0.01	0.09	-0.09	-0.43	0.01
Current Ratio	3.81	2.59	1.28	0.76	0.81	8.75
Quick Ratio	3.81	--	--	--	--	--
Interest Coverage	-837.67	-373.01	-516.31	-371.49	-3,008.67	-14.29

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	0.08	0.09	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	404.52	762.50	1,071.96	41,429.79	169,110.75
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.